A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)

Conditions:   Eosinophilic Gastritis;   Eosinophilic Duodenitis Interventions:   Drug: antolimab (AK002);   Other: Placebo Sponsor:   Allakos, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials